Alexion Pharmaceuticals v Amgen (UPC_Coa-405/2024) and Alexion Pharmaceuticals v Samsung Bioepis NL BV (UPC_CoA-402/2024); December 20, 2024.

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.

In the field of biopharmaceuticals, every technological innovation has the potential to revolutionize treatment strategies. Sanyou Bio's Intelligent Hundred-Trillion Molecule Library (AI-STAL) has ...

Enu Pharma, a biotech venture spun off from Hokkaido University, announced on January 31st that it has raised a total of 400 million yen in seed funding. The funding round, conducted in December ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals a new signaling mechanism ...

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Dr James Field, founder and CEO of LabGenius, a drug ...

Scientists have developed retriever, a computational tool that extracts disease-specific drug response signatures to predict the best combinations for cancer treatment.

Scientists at Stanford are developing a painless, topical vaccine using a common skin bacterium to trigger immunity.

Zafrens' breakthrough platform allows scientists to create and test hundreds of thousands of potential medicines in a single ...

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two investor conferences during the month of March.

In India, the "Big Four" - the spectacled cobra, common krait, Russell's viper, and saw-scaled viper - cause many deaths ...

Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.